pomalidomide has been researched along with Precancerous Conditions in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastea, LI; Copland, JA; Doeppler, H; Edenfield, B; Fleming, AK; Li, Z; Liou, GY; Pandey, V; Qiu, Y; Storz, P; Tun, HW; von Roemeling, CA | 1 |
1 other study(ies) available for pomalidomide and Precancerous Conditions
| Article | Year |
|---|---|
Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions.
Topics: Animals; Humans; Immunologic Factors; Interferon Regulatory Factors; Macrophages; Mice; Pancreatic Neoplasms; Precancerous Conditions; Thalidomide; Tumor Microenvironment; U937 Cells | 2019 |